NCT07154966View on ClinicalTrials.gov

Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

January 10, 2025

Study Completion Date

July 1, 2025

Conditions
Ovarian Cancer (OvCa)Fallopian Tube CancersEndometrial CancerChemotherapy-Induced Taste AlterationCancer-Associated MalnutritionCancer-Associated Sarcopeni
Interventions
OTHER

Standard Chemotherapy (Carboplatin-Paclitaxel)

Standard-of-care chemotherapy with carboplatin (AUC 5, every 21 days) and paclitaxel (175-200 mg/m², every 21 days) for six cycles. No additional drugs, dose modifications, or alternative regimens introduced.

Trial Locations (1)

06210

Ankara Etlik City Hospital, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV

NCT07154966 - Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy | Biotech Hunter | Biotech Hunter